Cargando…
Discovery of the Cryptic Sites of SARS-CoV-2 Papain-like Protease and Analysis of Its Druggability
In late 2019, a new coronavirus (CoV) caused the outbreak of a deadly respiratory disease, resulting in the COVID-19 pandemic. In view of the ongoing pandemic, there is an immediate need to find drugs to treat patients. SARS-CoV-2 papain-like cysteine protease (PLpro) not only plays an important rol...
Autores principales: | Qiu, Yue, Liu, Qing, Tu, Gao, Yao, Xiao-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569941/ https://www.ncbi.nlm.nih.gov/pubmed/36232570 http://dx.doi.org/10.3390/ijms231911265 |
Ejemplares similares
-
Crystal structure of the papain-like protease of MERS coronavirus reveals unusual, potentially druggable active-site features
por: Lei, Jian, et al.
Publicado: (2014) -
Deubiquitinating Activity of the SARS-CoV Papain-Like Protease
por: Barretto, Naina, et al.
Publicado: (2006) -
Crystal structure of SARS-CoV-2 papain-like protease
por: Gao, Xiaopan, et al.
Publicado: (2021) -
Supporting SARS-CoV-2 Papain-Like Protease Drug Discovery: In silico Methods and Benchmarking
por: Ibrahim, Tamer M., et al.
Publicado: (2020) -
Mechanism and inhibition of the papain‐like protease, PLpro, of SARS‐CoV‐2
por: Klemm, Theresa, et al.
Publicado: (2020)